Factors Predicting Falls in Parkinson’s Disease: Investigation of Motor, Non-motor Findings and Different Dual Task Activities
Journal Title: Turkish Journal of Neurology - Year 2020, Vol 26, Issue 2
Abstract
Objective: The purpose of this study was to identify the predictors of future falls in mild-to-moderate stage Parkinson’s disease (PD) without cognitive impairment. We evaluated motor findings, non-motor findings, and different cognitive dual tasks such as memory, attention, and executive functions added to the 10-meter walk test (10MWT), which has been used to measure walking speed in PD Materials and Methods: A total of 62 subjects were evaluated in terms of eligibility for the study. Thirty-six patients with PD who met the inclusion criteria were included in the study. Demographic characteristics were identified and clinical findings were examined. Motor and non-motor findings were evaluated using the Turkish version of the Movement Disorder Society-Unified PD Rating scale (MDS-UPDRS). Walking speed was measured with the 10MWT as single task and with different cognitive domains added to the 10MWT as cognitive dual task activities. After the initial evaluation, falls within six months were recorded. Results: The previous history of falls, high scores of MDS-UPDRS 1.A, MDS-UPDRS 1.B, and MDS-UPDRS 2, walking speed under a single task (10MWT) and different cognitive (memory, digit span-forwards, digit span-backwards, and serial 7s) dual tasks were significantly different in terms of the future falls within six months (p<0.05). According to the results of multiple logistic regression analysis using these variables, it was observed that the increase in 10MWT speed decreased the risk of future falls by 0.76 times, and an increase in MDS-UPDS 1.B score increased the risk of future falls by 2.06 times. Conclusion: In our study, in which the known risk factors associated with falls in PD were examined together, the risk of falls in patients with mild-to-moderate stage PD without cognitive impairment was found to be predicted by gait speed and the MDS-UPDRS 1.B score, which evaluated non-motor findings such as sleep disorder, sensory problems, and autonomic dysfunction.
Authors and Affiliations
Zeynep Tüfekçioğlu, Burcu Ersöz Hüseyinsinoğlu, Emrah Zirek, Başar Bilgiç, Hakan Gürvit, Haşmet Hanağası
Keywords
Related Articles
- EP ID EP685140
- DOI 10.4274/tnd.2019.71235
- Views 186
- Downloads 0
Seizures with Autonomic Symptoms and Sudden Unexpected Death in Epilepsy (SUDEP)
The autonomic nervous system, formerly the vegetative nervous system, is a division of the peripheral nervous system that supplies smooth muscle and glands, and thus influences the function of internal organs. The hypoth...
Reliability and Validity of the Turkish Version of the Mini-BESTest Balance Scale in Patients with Stroke
Objective: To determine the validity and reliability of the Turkish version of the Mini-BESTest balance scale (Mini-BESTest-Turk) and provide a culturally adapted version for use in Turkish patients with stroke. Materia...
Distribution Patterns and Publishing Rates of Oral Presentations Presented in National Neurology Congresses According to Diseases Between 2000-2017
Objective: Congresses are important for physicians to access up-to-date information. The papers presented in congresses provide access to current research topics in the field in a short time. In this study, we aimed to i...
Analysis of Peripapillary Retinal Nerve Fiber Layer and Macular Volume in Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Healthy Controls Using Spectral Domain Optical Coherence Tomography in a Turkish Cohort
Objective: To compare the peripapillary retinal nerve fiber layer (pRNFL) thickness and macular volume in patients with multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), and healthy controls. Mat...
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to...